| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| SRTSSensus Healthcare, Inc. | 81.47M | 4.96 | 12.10 | 71.31% | -8.44% | -5.87% | 0.01 | |
| CATXPerspective Therapeutics, Inc. | 184.36M | 2.48 | -2.02 | -100% | -197.29% | -42.77% | 0.01 | |
| TLSITriSalus Life Sciences, Inc. | 307.28M | 6.15 | -4.92 | 58.99% | -98.45% | |||
| PROFProfound Medical Corp. | 302.68M | 8.34 | -7.79 | 41.23% | -272.77% | -130.59% | 0.08 | |
| DCTHDelcath Systems, Inc. | 354.29M | 10.21 | -11.03 | 17.02% | 1.5% | 1.04% | 0.02 | |
| PTHLPheton Holdings Ltd Class A Ordinary Shares | 8.46M | 0.90 | -17.38 | -28.7% | -91.16% | -13.91% | 0.04 | |
| ARAYAccuray Incorporated | 98.61M | 0.87 | -56.13 | 2.68% | -4.28% | -31.22% | 2.17 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 0 | 0 | 3.9M | 1.91M | 4.17M | 7.3M | 6.87M | 6.68M | 7.2M | 10.17M |
| Revenue Growth % | - | - | - | -0.51% | 1.18% | 0.75% | -0.06% | -0.03% | 0.08% | 0.41% |
| Cost of Goods Sold | 119.03K | 187.01K | 2.41M | 1.31M | 1.78M | 3.83M | 3.92M | 3.66M | 2.82M | 3.47M |
| COGS % of Revenue | - | - | 0.62% | 0.68% | 0.43% | 0.52% | 0.57% | 0.55% | 0.39% | 0.34% |
| Gross Profit | -119.03K | -187.01K | 1.49M | 604.82K | 2.39M | 3.47M | 2.95M | 3.02M | 4.38M | 6.7M |
| Gross Margin % | - | - | 0.38% | 0.32% | 0.57% | 0.48% | 0.43% | 0.45% | 0.61% | 0.66% |
| Gross Profit Growth % | - | -0.57% | 8.96% | -0.59% | 2.95% | 0.45% | -0.15% | 0.02% | 0.45% | 0.53% |
| Operating Expenses | 8.09M | 11.64M | 15.51M | 15.43M | 17.29M | 22.34M | 33.24M | 35.15M | 33M | 38.17M |
| OpEx % of Revenue | - | - | 3.98% | 8.08% | 4.14% | 3.06% | 4.84% | 5.26% | 4.58% | 3.75% |
| Selling, General & Admin | 4.39M | 4.2M | 7.84M | 7.89M | 7.9M | 12.43M | 17.97M | 17.93M | 18.62M | 22.02M |
| SG&A % of Revenue | - | - | 2.01% | 4.13% | 1.89% | 1.7% | 2.61% | 2.68% | 2.59% | 2.17% |
| Research & Development | 3.7M | 7.43M | 7.66M | 7.54M | 9.4M | 9.91M | 15.28M | 14.69M | 14.38M | 16.15M |
| R&D % of Revenue | - | - | 1.97% | 3.94% | 2.25% | 1.36% | 2.22% | 2.2% | 2% | 1.59% |
| Other Operating Expenses | 0 | 1.57K | 3.65K | 3.75K | 0 | 0 | 0 | 2.52M | 0 | 0 |
| Operating Income | -11.22M | -15.64M | -17.63M | -14.83M | -14.9M | -18.86M | -30.29M | -32.13M | -28.62M | -31.47M |
| Operating Margin % | - | - | -4.52% | -7.76% | -3.57% | -2.58% | -4.41% | -4.81% | -3.97% | -3.1% |
| Operating Income Growth % | -1.59% | -0.39% | -0.13% | 0.16% | -0.01% | -0.27% | -0.61% | -0.06% | 0.11% | -0.1% |
| EBITDA | -11.14M | -15.45M | -16.75M | -13.15M | -13.39M | -17.32M | -28.41M | -30.52M | -27.47M | -30.58M |
| EBITDA Margin % | - | - | -4.29% | -6.88% | -3.21% | -2.37% | -4.13% | -4.57% | -3.82% | -3.01% |
| EBITDA Growth % | -1.62% | -0.39% | -0.08% | 0.22% | -0.02% | -0.29% | -0.64% | -0.07% | 0.1% | -0.11% |
| D&A (Non-Cash Add-back) | 85.77K | 187.01K | 876.42K | 1.68M | 1.51M | 1.54M | 1.88M | 1.6M | 1.15M | 891.06K |
| EBIT | -11.69M | -15.75M | -13.84M | -14.32M | -14.04M | -21.03M | -30.53M | -28.21M | -27.93M | -26.48M |
| Net Interest Income | -3.95M | -498.62K | -970.25K | -400.18K | -675K | 149K | 136.78K | 882.59K | 872K | 1.37M |
| Interest Income | 99.24K | 117.25K | 101.58K | 355.2K | 363K | 692K | 203.2K | 1.05M | 1.64M | 1.37M |
| Interest Expense | 4.05M | 615.87K | 1.07M | 755.37K | 1.04M | 543K | 66.41K | 167.1K | 770K | 0 |
| Other Income/Expense | -1.1M | -672.3K | 2.72M | -247.72K | -171K | -2.71M | -303K | 3.74M | -81K | 4.99M |
| Pretax Income | -12.32M | -12.14M | -14.91M | -15.07M | -15.07M | -21.58M | -30.59M | -28.38M | -28.7M | -26.48M |
| Pretax Margin % | - | - | -3.82% | -7.89% | -3.61% | -2.95% | -4.45% | -4.25% | -3.99% | -2.6% |
| Income Tax | -523.22K | 10.46K | 58.94K | 169.44K | 147K | 45K | 105K | 287K | -128K | -1.9K |
| Effective Tax Rate % | 0.96% | 1% | 1% | 1.01% | 1.01% | 1% | 1% | 1.01% | 1% | 1% |
| Net Income | -11.8M | -12.15M | -14.97M | -15.24M | -15.22M | -21.62M | -30.7M | -28.67M | -28.57M | -26.48M |
| Net Margin % | - | - | -3.84% | -7.98% | -3.65% | -2.96% | -4.47% | -4.29% | -3.97% | -2.6% |
| Net Income Growth % | -0.44% | -0.03% | -0.23% | -0.02% | 0% | -0.42% | -0.42% | 0.07% | 0% | 0.07% |
| Net Income (Continuing) | -16.38M | -16.33M | -18.82M | -15.24M | -15.22M | -21.62M | -30.7M | -28.67M | -28.57M | -26.48M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -4.98 | -2.93 | -2.44 | -1.52 | -1.39 | -1.25 | -1.50 | -1.38 | -1.35 | -1.07 |
| EPS Growth % | 0.87% | 0.41% | 0.17% | 0.38% | 0.09% | 0.1% | -0.2% | 0.08% | 0.02% | 0.21% |
| EPS (Basic) | -4.98 | -2.93 | -2.44 | -1.52 | -1.39 | -1.25 | -1.50 | -1.38 | -1.35 | -1.07 |
| Diluted Shares Outstanding | 2.37M | 4.15M | 6.14M | 10.04M | 11.09M | 17.29M | 20.47M | 20.83M | 21.18M | 24.77M |
| Basic Shares Outstanding | 2.37M | 4.15M | 6.14M | 10.04M | 11.09M | 17.29M | 20.46M | 20.83M | 21.18M | 24.77M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 15.08M | 16.72M | 14M | 27.84M | 22.84M | 97.74M | 77.02M | 62.02M | 41.9M | 69.06M |
| Cash & Short-Term Investments | 14.79M | 15.5M | 8.83M | 22.53M | 14.82M | 83.91M | 67.06M | 46.52M | 26.21M | 54.91M |
| Cash Only | 7.58M | 15.5M | 8.83M | 22.53M | 14.82M | 83.91M | 67.06M | 46.52M | 26.21M | 54.91M |
| Short-Term Investments | 7.21M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 5.7M | 3.57M | 1.52M | 3.31M | 7.43M | 1.41M | 6.34M | 7.29M | 7.04M |
| Days Sales Outstanding | - | - | 334.27 | 289.58 | 289.84 | 371.35 | 74.88 | 346.59 | 369.51 | 252.91 |
| Inventory | 0 | 310.11K | 1.14M | 2.67M | 3.67M | 5.33M | 7.4M | 7.94M | 6.99M | 5.8M |
| Days Inventory Outstanding | - | 605.27 | 172.27 | 745.31 | 751.72 | 508.05 | 689.13 | 791.93 | 905.57 | 610.53 |
| Other Current Assets | 100.39K | 518.49K | 458.07K | 224.87K | 1.03M | 1.07M | 1.15M | 0 | 0 | 0 |
| Total Non-Current Assets | 188.52K | 904.48K | 8.17M | 6.34M | 7.27M | 6.86M | 9.64M | 2.4M | 2.06M | 1.17M |
| Property, Plant & Equipment | 165.1K | 709.05K | 1.37M | 886.44K | 2.22M | 2.28M | 1.9M | 1.72M | 1.57M | 821.01K |
| Fixed Asset Turnover | - | - | 2.84x | 2.16x | 1.88x | 3.20x | 3.61x | 3.89x | 4.59x | 12.38x |
| Goodwill | 0 | 0 | 2.71M | 2.5M | 2.63M | 2.68M | 2.69M | 0 | 0 | 0 |
| Intangible Assets | 23.42K | 195.44K | 4.09M | 2.95M | 2.41M | 1.9M | 1.43M | 680K | 490K | 261K |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 3.62M | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 15.27M | 17.63M | 22.17M | 34.18M | 30.11M | 104.6M | 86.66M | 64.42M | 43.96M | 70.23M |
| Asset Turnover | - | - | 0.18x | 0.06x | 0.14x | 0.07x | 0.08x | 0.10x | 0.16x | 0.14x |
| Asset Growth % | 9.38% | 0.15% | 0.26% | 0.54% | -0.12% | 2.47% | -0.17% | -0.26% | -0.32% | 0.6% |
| Total Current Liabilities | 913.01K | 3.68M | 8.53M | 5.79M | 8.24M | 4.81M | 4.15M | 4.18M | 6.37M | 6.57M |
| Accounts Payable | 0 | 1.32M | 4.04M | 2.87M | 3.03M | 3.38M | 3.18M | 2.03M | 865K | 1.32M |
| Days Payables Outstanding | - | 2.58K | 611.71 | 802.93 | 620.55 | 322.31 | 295.62 | 202.74 | 112.08 | 138.61 |
| Short-Term Debt | 206.6K | 2.14M | 3.74M | 983.52K | 4.17M | 312K | 249.66K | 523K | 2.1M | 1.74M |
| Deferred Revenue (Current) | 0 | 192.91K | 191.9K | 229.48K | 504.93K | 358K | 476.35K | 471K | 721K | 419K |
| Other Current Liabilities | 706.41K | 29.28K | 586.19K | 1.48M | 521.75K | 744K | 247.66K | 621K | 1.42M | 1.03M |
| Current Ratio | 16.52x | 4.54x | 1.64x | 4.81x | 2.77x | 20.32x | 18.56x | 14.82x | 6.58x | 10.52x |
| Quick Ratio | 16.52x | 4.46x | 1.51x | 4.35x | 2.33x | 19.22x | 16.78x | 12.92x | 5.48x | 9.64x |
| Cash Conversion Cycle | - | - | -105.16 | 231.96 | 421.01 | 557.09 | 468.39 | 935.77 | 1.16K | 724.83 |
| Total Non-Current Liabilities | 4.29M | 2.91M | 2.4M | 8.84M | 7.48M | 2.44M | 2M | 8.23M | 6.36M | 3.25M |
| Long-Term Debt | 5.56M | 3.87M | 352.98K | 10.62M | 5.18M | 0 | 0 | 6.65M | 5M | 2.92M |
| Capital Lease Obligations | 0 | 0 | 0 | -2.82M | 1.64M | 1.36M | 1.13M | 817K | 504K | 203K |
| Deferred Tax Liabilities | 0 | 0 | -284.95K | 250.64K | 0 | 0 | 0 | 0 | 59K | 0 |
| Other Non-Current Liabilities | -1.27M | -961.24K | 2.04M | -2.3M | 14.65K | 0 | 0 | 0 | 73K | 71K |
| Total Liabilities | 5.21M | 6.59M | 10.93M | 14.63M | 15.71M | 7.25M | 6.15M | 12.42M | 12.73M | 9.81M |
| Total Debt | 4.21M | 4.94M | 4.09M | 8.78M | 10.99M | 1.68M | 1.38M | 8.23M | 7.87M | 5.12M |
| Net Debt | -3.37M | -10.56M | -4.74M | -13.75M | -3.84M | -82.24M | -65.69M | -38.29M | -18.35M | -49.79M |
| Debt / Equity | 0.42x | 0.45x | 0.36x | 0.45x | 0.76x | 0.02x | 0.02x | 0.16x | 0.25x | 0.08x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -2.77x | -25.40x | -16.45x | -19.63x | -14.36x | -34.74x | -456.12x | -192.25x | -37.16x | - |
| Total Equity | 10.06M | 11.04M | 11.25M | 19.55M | 14.39M | 97.35M | 80.51M | 52M | 31.22M | 60.42M |
| Equity Growth % | 6.35% | 0.1% | 0.02% | 0.74% | -0.26% | 5.76% | -0.17% | -0.35% | -0.4% | 0.94% |
| Book Value per Share | 4.25 | 2.66 | 1.83 | 1.95 | 1.30 | 5.63 | 3.93 | 2.50 | 1.47 | 2.44 |
| Total Shareholders' Equity | 10.06M | 11.04M | 11.25M | 19.55M | 14.39M | 97.35M | 80.51M | 52M | 31.22M | 60.42M |
| Common Stock | 48.34M | 61.95M | 78.22M | 88.79M | 100.46M | 211.53M | 219.28M | 205.82M | 222.21M | 281.55M |
| Retained Earnings | -39.72M | -53.16M | -71.79M | -81.52M | -101.07M | -129.99M | -160.48M | -189.36M | -217.35M | -245.17M |
| Treasury Stock | 0 | 0 | -4.85M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 8.42K | -46.07K | -21.07K | -90.37K | 4.57M | 4.74M | 16.84M | 5.57M | 2.74M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -4.94M | -10.79M | -11.81M | -13.43M | -15.45M | -20.57M | -22.36M | -25.8M | -22.61M | -23.45M |
| Operating CF Margin % | - | - | -3.03% | -7.03% | -3.7% | -2.82% | -3.25% | -3.86% | -3.14% | -2.31% |
| Operating CF Growth % | -0.72% | -1.18% | -0.09% | -0.14% | -0.15% | -0.33% | -0.09% | -0.15% | 0.12% | -0.04% |
| Net Income | -11.8M | -12.15M | -14.97M | -15.24M | -15.57M | -21.62M | -30.7M | -28.67M | -28.32M | -27.82M |
| Depreciation & Amortization | 85.77K | 139.13K | 693.31K | 1.23M | 1.55M | 1.54M | 1.88M | 1.6M | 929K | 936K |
| Stock-Based Compensation | 464.61K | 745.15K | 1.06M | 797.49K | 0 | 3.02M | 7.21M | 4.24M | 3.42M | 2.58M |
| Deferred Taxes | -1.55M | 7.62K | 0 | -70.94K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 7.54M | 617.44K | 1.9M | 847.17K | 1.72M | 1.13M | 132K | 2.66M | 828K | 255K |
| Working Capital Changes | 311.39K | -151.93K | -501.61K | -990.83K | -3.15M | -4.63M | -877K | -5.63M | 540K | 591K |
| Change in Receivables | 1.1M | -611.9K | -3.17M | 1.15M | -872.97K | -3.85M | 2M | -1.42M | -956K | 186K |
| Change in Inventory | 0 | -310.11K | -806.63K | -1.62M | -873.6K | -2.14M | -2.49M | -1.86M | 353K | 656K |
| Change in Payables | -65.16K | 577.17K | 2.68M | -857.06K | -18.63K | 102K | -356K | -566K | 1.35M | 815K |
| Cash from Investing | -6.49M | 6.63M | -793.18K | 0 | -192.79K | -350K | -593K | 0 | 0 | 0 |
| Capital Expenditures | -120.35K | -808.84K | -369.5K | 0 | -192.79K | -350K | -32K | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | 0.09% | - | 0.05% | 0.05% | 0% | - | - | - |
| Acquisitions | - | - | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 7.44M | 0 | 0 | 0 | 0 | -561K | 0 | 0 | 0 |
| Cash from Financing | 18.73M | 11.83M | 6.12M | 27.81M | 6.8M | 87.43M | 5.95M | 7.03M | 1.76M | 54.7M |
| Debt Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - | - | - | - |
| Other Financing | -553.18K | -4.14M | -604.21K | -6.57M | -1.27M | 11.52M | 6.33M | 114K | 2.67M | -4.85M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | -5.06M | -11.6M | -12.18M | -13.43M | -15.45M | -20.92M | -22.95M | -25.8M | -22.61M | -23.45M |
| FCF Margin % | - | - | -3.12% | -7.03% | -3.7% | -2.86% | -3.34% | -3.86% | -3.14% | -2.31% |
| FCF Growth % | -0.72% | -1.29% | -0.05% | -0.1% | -0.15% | -0.35% | -0.1% | -0.12% | 0.12% | -0.04% |
| FCF per Share | -2.14 | -2.79 | -1.98 | -1.34 | -1.39 | -1.21 | -1.12 | -1.24 | -1.07 | -0.95 |
| FCF Conversion (FCF/Net Income) | 0.42x | 0.89x | 0.79x | 0.88x | 1.01x | 0.95x | 0.73x | 0.90x | 0.79x | 0.89x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 43K | 669K | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 55K | 160K | 0 |
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -206.48% | -115.14% | -134.34% | -99.01% | -89.69% | -38.7% | -34.52% | -43.27% | -68.65% | -57.79% |
| Return on Invested Capital (ROIC) | -179.66% | -327.19% | -378.57% | -180.77% | -136.7% | -110.22% | -151.78% | -168.85% | -161.4% | -200.82% |
| Gross Margin | - | - | 38.18% | 31.66% | 57.26% | 47.56% | 42.95% | 45.22% | 60.87% | 65.89% |
| Net Margin | - | - | -383.77% | -797.88% | -364.69% | -296.03% | -446.66% | -429.11% | -396.85% | -260.45% |
| Debt / Equity | 0.42x | 0.45x | 0.36x | 0.45x | 0.76x | 0.02x | 0.02x | 0.16x | 0.25x | 0.08x |
| Interest Coverage | -2.77x | -25.40x | -16.45x | -19.63x | -14.36x | -34.74x | -456.12x | -192.25x | -37.16x | - |
| FCF Conversion | 0.42x | 0.89x | 0.79x | 0.88x | 1.01x | 0.95x | 0.73x | 0.90x | 0.79x | 0.89x |
| Revenue Growth | - | - | - | -51.01% | 118.47% | 74.99% | -5.9% | -2.79% | 7.75% | 41.23% |
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Recurring - Non-Capital | - | - | - | - | - | 8.24M |
| Recurring - Non-Capital Growth | - | - | - | - | - | - |
| Capital Equipment | - | - | - | - | - | 2.44M |
| Capital Equipment Growth | - | - | - | - | - | - |
| Capital equipment | - | - | 3.15M | 2M | 6.81M | - |
| Capital equipment Growth | - | - | - | -36.38% | 239.62% | - |
| Recurring - non-capital | - | - | 3.29M | 4.68M | 393K | - |
| Recurring - non-capital Growth | - | - | - | 42.03% | -91.60% | - |
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| UNITED STATES | - | - | - | - | - | 7.35M |
| UNITED STATES Growth | - | - | - | - | - | - |
| CALIFORNIA | - | - | - | - | - | 2.44M |
| CALIFORNIA Growth | - | - | - | - | - | - |
| DELAWARE | - | - | - | - | - | 891K |
| DELAWARE Growth | - | - | - | - | - | - |
| USA | - | - | 2.09M | 3.4M | 5.13M | - |
| USA Growth | - | - | - | 62.44% | 50.99% | - |
| Germany | - | - | 1.43M | 1.8M | 1.84M | - |
| Germany Growth | - | - | - | 25.95% | 2.62% | - |
| Canada | - | - | 1.72M | 1.49M | 230K | - |
| Canada Growth | - | - | - | -13.57% | -84.56% | - |
| C | 3M | 4.76M | - | - | - | - |
| C Growth | - | 58.61% | - | - | - | - |
| D | 1.89M | 1.47M | - | - | - | - |
| D Growth | - | -22.33% | - | - | - | - |
Profound Medical Corp. (PROF) reported $15.4M in revenue for fiscal year 2024.
Profound Medical Corp. (PROF) grew revenue by 41.2% over the past year. This is strong growth.
Profound Medical Corp. (PROF) reported a net loss of $42.0M for fiscal year 2024.
Profound Medical Corp. (PROF) has a return on equity (ROE) of -57.8%. Negative ROE indicates the company is unprofitable.
Profound Medical Corp. (PROF) had negative free cash flow of $37.5M in fiscal year 2024, likely due to heavy capital investments.